Search Result "TGF-β1."
Therapeutic Potential of Targeting Transforming Growth Factor-beta(TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer
Journal: Current Drug Targets
Volume: 24 Issue: 17 Year: 2023 Page: 1335-1345
Author(s):
Cytokines in Neuroinflammation and Alzheimers Disease
Journal: Current Drug Targets
Volume: 5 Issue: 6 Year: 2004 Page: 529-534
Author(s): Mathias Cacquevel, Nathalie Lebeurrier, Simon Cheenne, Denis Vivien
Activin and TGF-β Effects on Brain Development and Neural Stem Cells
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 7 Year: 2012 Page: 844-855
Author(s): Griselda Rodriguez-Martinez,Ivan Velasco
The Axis of Thrombospondin-1, Transforming Growth Factor Beta and Connective Tissue Growth Factor: An Emerging Therapeutic Target in Rheumatoid Arthritis
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 3 Year: 2010 Page: 338-343
Author(s): Mario C. Rico, James J. Rough, Fabiola E. Del Carpio-Cano, Satya P. Kunapuli, Raul A. DeLa Cadena
Insights on Biology and Pathology of HIF-1α/-2α, TGFβ/BMP, Wnt/β-Catenin, and NF-κB Pathways in Osteoarthritis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3293-3312
Author(s): Longhuo Wu,Xianhua Huang,Linfu Li,Hao Huang,Ruian Xu,Walter Luyten
TGF-beta Signaling in Cancer Treatment
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 17 Year: 2014 Page: 2934-2947
Author(s): Isabel Fabregat,Joan Fernando,Jessica Mainez,Patricia Sancho
Central Role of Transforming Growth Factor Type Beta 1 in Skeletal Muscle Dysfunctions: An Update on Therapeutic Strategies
Journal: Current Protein & Peptide Science
Volume: 19 Issue: 1 Year: 2018 Page: 1189-1200
Author(s): Johanna Abrigo,Felipe Simon,Daniel Cabrera,Gonzalo Cordova,Capucine Trollet,Claudio Cabello-Verrugio
Low Density Lipoprotein Receptor-Related Proteins (LRPs), Alzheimers and Cognition
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4 Issue: 5 Year: 2005 Page: 469-480
Author(s): M. E. Harris-White, S. A. Frautschy
Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?
Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 1891-1899
Author(s): Martin A. Krasnapolski, Laura B. Todaro, Elisa Bal de Kier Joffe
Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 1 Year: 2017 Page: 93-101
Author(s): Rodica Balasa,Smaranda Maier,Septimiu Voidazan,Adina Hutanu,Zoltan Bajko,Anca Motataianu,Brandusa Tilea,Cristina Tiu